Table 2 Comorbidity distribution of COVID-19 patients.
From: Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Comorbidities | All patients | RDV | RDV + CORT | p |
|---|---|---|---|---|
Arterial hypertension | 233 | 112 | 121 | .59 |
Coronary heart disease | 38 | 15 | 23 | .23 |
Chronic heart failure | 18 | 9 | 9 | 1 |
Diabetes | 134 | 57 | 67 | .38 |
COPD | 24 | 10 | 14 | .38 |
Asthma | 17 | 11 | 6 | .32 |
Chronic renal disease | 17 | 8 | 9 | 1 |
Chronic hepatic disease | 8 | 2 | 5 | .33 |
Oncologic disease | 46 | 23 | 23 | 1 |
HIV infection | 3 | 2 | 1 | .61 |